These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 38622310)

  • 1. Targeting immunogenic cell stress and death for cancer therapy.
    Galluzzi L; Guilbaud E; Schmidt D; Kroemer G; Marincola FM
    Nat Rev Drug Discov; 2024 Jun; 23(6):445-460. PubMed ID: 38622310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
    Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
    Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
    Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
    Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Sep; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
    Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
    Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbes mediated immunogenic cell death in cancer immunotherapy.
    Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
    Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
    Chen Q; Li C; Wang Q
    Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
    Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
    Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines in immunogenic cell death: Applications for cancer immunotherapy.
    Showalter A; Limaye A; Oyer JL; Igarashi R; Kittipatarin C; Copik AJ; Khaled AR
    Cytokine; 2017 Sep; 97():123-132. PubMed ID: 28648866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy.
    Sun D; Zhang J; Wang L; Yu Z; O'Driscoll CM; Guo J
    Drug Discov Today; 2021 Mar; 26(3):651-662. PubMed ID: 33278602
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted Enrichment of Enzyme-Instructed Assemblies in Cancer Cell Lysosomes Turns Immunologically Cold Tumors Hot.
    Ji S; Li J; Duan X; Zhang J; Zhang Y; Song M; Li S; Chen H; Ding D
    Angew Chem Int Ed Engl; 2021 Dec; 60(52):26994-27004. PubMed ID: 34643312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
    Yu S; Xiao H; Ma L; Zhang J; Zhang J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliciting Immunogenic Cell Death via a Unitized Nanoinducer.
    Dai Z; Tang J; Gu Z; Wang Y; Yang Y; Yang Y; Yu C
    Nano Lett; 2020 Sep; 20(9):6246-6254. PubMed ID: 32786942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
    Li W; Jiang Y; Lu J
    Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
    Peng J; Li S; Ti H
    Int J Nanomedicine; 2024; 19():5895-5930. PubMed ID: 38895146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.